期刊文献+

CysC与NT-proBNP水平在慢性心力衰竭中的变化及意义 被引量:32

Changes of CysC and NT-proBNP in patients with chronic heart failure and their clinical significance
暂未订购
导出
摘要 目的观察慢性心力衰竭(chronic heart failure,CHF)患者血清胱抑素C(Cystatin C,CysC)以及N端脑钠肽前体(N-Terminal pro-brain natriuretic peptide,NT-proBNP)水平的变化,并探讨其临床意义。方法将57例CHF患者按照美国纽约心脏病学会心功能分级标准(New York Heart Association,NYHA)进行分级,分为Ⅱ、Ⅲ、Ⅳ级。选取健康对照组51例。分别测定血清CysC、血浆NT-proBNP水平以及左室射血分数(left ventricularejection fraction,LVEF),并进行相关性分析。结果 CHF组血清CysC以及血浆NT-proBNP水平高于健康对照组(P<0.01),并且CHF组内随着CHF程度的加重,CysC以及NT-proBNP的水平也升高。相关性分析发现,CHF组血清CysC与LVEF呈中等负相关(r=-0.793,P<0.01),CHF组血浆NT-proBNP与LVEF呈中等负相关(r=-0.618,P<0.01),CHF组血清CysC与血浆NT-proBNP呈中等正相关(r=0.742,P<0.01)。结论血清CysC以及血浆NT-proBNP与心力衰竭密切相关,可以反映CHF的心功能,有利于临床上对心力衰竭的早期诊断和治疗。 Objective To observe changes of concentrations of cystatin C and NT-proBNP levels in patients with heart failure and evaluate the clinical significance of cystatin C and NT-proBNP levels.Methods Serum cystatin C levels,plasma NT-proBNP levels and LVEF were measured in 57 patients with heart failure in New York Heart Association(NYHA)class Ⅱto Ⅳ,these were compared with 51 control subjects without heart failure.Results cystatin C and NT-proBNP levels were higher in patients with heart failure than control subjects(P0.01),and increased follow heart failure progress.Cystatin C and NT-proBNP levels were negatively related to LVEF.Serum levels of cystatin C were positively related to plasma levels of NT-proBNP.Conclusion cystatin C and NT-proBNP levels can reflect the state of cardiac function,and could become useful tools in facilitating early diagnosis and adequate treatment.
出处 《检验医学与临床》 CAS 2013年第2期146-148,共3页 Laboratory Medicine and Clinic
关键词 胱抑素C N端脑钠肽前体 慢性心力衰竭 心功能 CysC NT-proBNP CHF heart function
  • 相关文献

参考文献19

  • 1Filler G,Bokenkamp A,Hofmann W. Cystatin C as a marker of GFR-history,indication,and future research[J].Clinical Biochemistry,2005,(01):1-8.
  • 2Arimoto T,Takeishi Y,Niizeki T. Cystatin C,a novel measure of renal function,is an independent predictor of cardiac events in patients with heart failure[J].Journal of Cardiac Failure,2005,(08):595-601.
  • 3Lassus J,Harjola M. Cystatin C:a step forward in assessing kidney function and cardiovascular risk[J].Heart Failure Reviews,2012,(02):251-261.
  • 4Palazzuoli A,Gallotta M,Quatrini I. Natriuretic peptides(BNP and NT-proBNP):measurement and relevance in heart failure[J].Vasc Health Risk Manag,2010,(03):411-418.
  • 5周红,孙跃民,万征.影响慢性心力衰竭患者预后指标的研究进展[J].中国慢性病预防与控制,2010,18(1):99-101. 被引量:9
  • 6Lee M,Saver JL,Huang WH. Impact of elevated cystatin C level on cardiovascular disease risk in predominantly high cardiovascular risk population:a meta-analysis[J].Circ Cardiovasc Qual Outcomes,2010,(06):675-683.
  • 7Shlipark MG,Samak MJ,Katz R. Cystatin C and the risk of death and cardiovascular events among elderly persons[J].New England Journal of Medicine,2005,(20):2049-2060.
  • 8Ix JH,Shlipak MG,Chertow GM. Cystatin,left ventricular hypertrophy,and diastolic dysfunction:data from the heart and soul study[J].Journal of Cardiac Failure,2006,(08):601-607.doi:10.1016/j.cardfail.2006.07.005.
  • 9Schrier RW,Abraham WT. Hormones and hemodynamics in heart failure[J].New England Journal of Medicine,1999,(01):577-585.
  • 10Patel PC,Ayers CR,Murphy SA. Association of cystatin C with left ventricular structure and function:the Dallas heart study[J].Circ Heart Fail,2009,(02):98-104.

二级参考文献23

  • 1Braunwald E.Clinical manifestations of heart failure[M].In:Braunwald E,editor.Heart disease:a textbook of cardiovascular medicine.Philadel- phia: WB Saunders,1980:493-494.
  • 2Eric J, Eichhorn MD.Prognosis determination in heart failure [J].Am J reed,200 1, 110:14-36.
  • 3Wilson T. B-type natriuretic peptide: a critical review [J]. Congest Heart Fail, 2007, 13:4-8-52.
  • 4Alter P, Rupp H, Rominger MB,et al.Relation of B-type natriuretic peptide to left ventricular wall stress as assessed by cardiac magnetic resonance imaging in patients with dilated ardiomyopathy[J].Can J Physiot Pharmacol,2007, 85:790-799.
  • 5O' Donoghue M,Kenney P, Oest RE, et al.Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department [J].Am J Cardiol,2007,100:1336-1340,.
  • 6Michele E, Claudio P.Comparison of brain natriuretic peptide (BNP)and amino-terminal proBNP for early diagnosis of heart failure[J].Clin Chem, 2007,53:1289-1297.
  • 7Squire IB, O'Brien R J, Demme B,et al.N-terminal pro-atrial natriuretic peptide and N-terminal pro-B-type natriuretic peptide in the prediction of death and heart failure in unselected patients following acute myocardial infarction[J].Clin Sci,2004, 107:309-316.
  • 8Kenneth D, Alain CS,Gerasimos F,et aI.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure [J].European Heart Journal,2008,29:2388-2422.
  • 9Kato H,Kashiwagi H,Shiraga M,et al.Adiponectin acts as an endogenous antit hrombotic factor[J].Arterioscl Thromb Vasc Biol,2006, 26:224-230.
  • 10George J, Patal S, Wexler D,et al.Circulating adiponectin concentrations in patients with congestive heart failure[J].Heart,2006,92:1420-1424.

共引文献8

同被引文献249

  • 1李治国,周霞,张浩,齐丽荣.胱抑素C、同型半胱氨酸及N末端B型利钠肽原检测在老年慢性心力衰竭患者中的应用[J].中国老年学杂志,2014,34(11):3137-3138. 被引量:19
  • 2赵志宏,单江,项美香,鲍晓峰,徐耕,傅国胜.氟伐他汀对大鼠心肌梗死后心室重塑的影响[J].中国病理生理杂志,2004,20(8):1444-1448. 被引量:6
  • 3Palazzuoli A, Gallotta M, Quatrini I, et al. Natriuretic peptides(BNP and NT-proBNP): measurement and relevance in heart failure[J]. Vasc Health Risk Manag,2010,6(3):411-418.
  • 4Grubb A. Non-invasive estimation of g[omerular filtration rate (GFR). The Lund model: Simultaneous use of cystatin C- and creatinine-based GFR-prediction equations, clinical data and an internal quality check [ J ]. Scand J Clin Lab Invest, 2010,70 (2) :65-70.
  • 5Kshatriya S, Kozman H, Siddiqui D, et al. The eardiorenal syn- drome in heart failure: an evolving paradigm[ J]. Am J Med Sei, 2010,340( 1 ) :33-37.
  • 6Patel PC, Ayers CR, Murphy SA, et al. Association of cystatin G with left ventricular structure and function: the Dallas Heart Study [J]. Circ Heart Fail,2009,2(2) :98-104.
  • 7Lassus J, Harjola VP. Cystatin C ~ a step forward in assessing kid- ney function and cardiovascular risk[ J]. Heart Fail Rev ,2012,17 (2) :251-261.
  • 8Lee M, Saver JL, Huang WH, et al. Impact of elevated cystatin C level on cardiovascular disease risk in predominantly high car- diovascular risk populations : a meta-analysis [ J ]. Circ Cardio- vasc Qual Outcomes,2010,3 (6) :675-683.
  • 9Taglieri N, Koenig W, Kaski .IC. Cystatin C and cardiovascular risk[J]. Ann Biol Clin (Paris) ,2010,68(5) :517-529.
  • 10张丽,张春玲,丛祥凤,张健,陈曦.N末端B型钠尿肽原和大内皮素-1对严重心力衰竭患者的预后作用及其与心血管病关系的研究[J].中华检验医学杂志,2007,30(11):1237-1241. 被引量:12

引证文献32

二级引证文献246

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部